Drugs / BEMA Buprenorphine NX
last change May 2017 re-read 2 minutes ago

BEMA Buprenorphine NX

Developed for
opiate dependence
Investigated by
BioDelivery Sciences International

Trials 1 · a red edge is where a trial was stopped

201820192020202120222023202420252026
PhaseRegistry idDatesIndicationSponsorStatusOutcome
Phase 3 NCT02516436 ? → May 2017 opiate dependence BioDelivery Sciences International Withdrawn No outcome recorded

Evidence & citations 2 cited values

Every value below carries the sentence it was read from. 1 source stands behind the page.

FieldValueCited text
Known as BEMA Buprenorphine NX ClinicalTrials.gov intervention name — accepted as the source's own label NCT02516436
Route Other “Buprenorphine with naloxone in a buccal film” NCT02516436